Long-term results after combined modality treatment for non-metastatic osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term results after combined modality treatment for non-metastatic osteosarcoma

Published:1999-12 Issue:4 Volume:16 Page:255-260
ISSN:0736-0118
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Aparicio J,Segura A,Montalar J,Garcerá S,Oltra A,Santaballa A,Yuste A,Pastor M,Munárriz B

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy,Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF02785871.pdf

Reference23 articles.

1. Whelan JS. Osteosarcoma.Eur J Cancer 1997;33A: 1611–1619.

2. Rosen Get al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumour to preoperative chemotherapy.Cancer 1982;49: 1221–1230.

3. Meyers PAet al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.J Clin Oncol 1992;10: 5–15.

4. Saeter Get al. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.J Clin Oncol 1991;9: 1766–1775.

5. Provisor AJet al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.J Clin Oncol 1997;15: 76–84.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma;Medicine;2018-05

2. Pre-treatment serum lactate dehydrogenase (LDH) and serum alkaline phosphatase (ALP) as prognostic factors in patients with osteosarcoma;Journal of Cancer Prevention & Current Research;2018-03-20

3. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis;Journal of Cancer Research and Therapeutics;2018

4. Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients;Pharmacogenomics;2016-12

5. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma;European Journal of Cancer Care;2016-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3